background image
New research strategy
Improving Human Health: RCSI's Strategy
for Excellence in Translational Research
2014-2020 was launched at an event
attended by Minister for Skills, Research
and Innovation, Damien English, in
November 2014. The strategy will focus
on innovative research that leads to
better diagnostics, therapeutics and
devices. It will also tackle important
healthcare delivery issues, inform policy
and clinical practice, and enhance
the quality of education of healthcare
professionals. The plans for developing
research and innovation at RCSI are
based on RCSI's current strategic
roadmap, Growth & Excellence 2013-
Strategic initiatives in research and
RCSI will invest in a major drive to
expand its educational and research
activities by establishing a Strategic
Academic Recruitment (StAR)
programme. These plans include the
establishment of 20 research lectureships
and 20 associate professorships,
along with additional methodological
and biostatistical supports, PhD and
MD studentships and infrastructural
developments. This significant
investment in our people and our
infrastructure supports the College's
aims to deliver excellence in education
for our students and to transfer research
discoveries more quickly into clinical
practice for the benefit of patients.
The College will also create a Health
Outcomes Research Centre that will
focus on how the Irish health system
impacts upon healthcare outcomes.
The centre will initially focus on surgical
outcomes and identify ways of improving
patient care by evidence-based best
Communication of high-impact research
In this annual reporting period (July 1,
2014 to June 30, 2015), researchers at
RCSI published a total of 375 PubMed
indexed articles, communicating research
findings in a very broad range of health
science disciplines. This is a brief sample
selected from the array of articles
published in exceptionally high-impact
journals where the senior author was an
RCSI staff member.
Research to guide GP management of
Researchers from RCSI have conducted
a new clinical review that provides
guidance for doctors on how to best
organise and prioritise care for patients
who suffer from multiple chronic medical
conditions (multimorbidity). The study
was carried out by the Health Research
Board (HRB) Centre for Primary Care
Research at RCSI's Department of
General Practice, in collaboration with
researchers from the University of Bristol
and the University of Dundee, UK. The
study, entitled "Managing patients with
multimorbidity in primary care", was
published in the BMJ (2015 January; 350:
h176). The first author on the paper was
Dr Emma Wallace, with Professor Susan
Smith as senior author.
Impaired bacterial killing by neutrophils
in cystic fibrosis
Professor Gerry McElvaney, and
his team of researchers from RCSI,
made an important breakthrough in
understanding the mechanisms behind
impaired bacterial killing by neutrophils
in individuals with cystic fibrosis (CF).
The research was carried out by RCSI in
Professor Ray Stallings,
Director of Research
The launch of a new strategy for excellence in translational research and the
announcement of a
50m investment in both its educational and research
activities were among the highlights in a hugely significant year for research
at RCSI. As an exclusively health sciences-focused institution with strong links
to acute hospitals and institutions that reflect the wide diversity of healthcare
facilities and needs, RCSI is uniquely placed to develop and enhance translational
research for the benefit of patients and the healthcare system. Its new five-
year investment plan is set to create 100 research jobs, including 40 full-time
academic posts, and will provide new laboratories and facilities to support their
The strategy will
focus on innovative
research that leads
to better diagnostics,
therapeutics and
Professor Ray Stallings, Director of Research, RCSI,
and Minister Damien English T.D., Minister for
Skills, Research and Innovation at the launch of the
College's new research strategy.